The GOOD trial is the first randomised controlled double-blind, double-dummy trial to directly compare efficacy between an alginate and a PPI with heartburn as the clinical primary endpoint. It showed ...
Hosted on MSN
Omeprazole NHS Warning: Hidden Dangers Exposed as Millions Risk Severe Side Effects from Long-Term Use
The National Health Service (NHS) has issued a stark warning over the widespread use of omeprazole, one of the most common treatments for heartburn and acid reflux, amid fears that millions of people ...
Additionally, omeprazole can also cause certain medications to become less effective or function differently than originally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback